What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

Oncology Today with Dr Neil Love

EpisodeNov 8, 202456m

What Clinicians Want to Know About the Current and Future Role of EZH1/2 Inhibitors in the Care of Patients with Lymphoma

Oncology Today with Dr Neil Love

EpisodeNov 8, 202456m

Dr Gilles Salles from the Memorial Sloan Kettering Cancer Center in New York, New York, reviews current and novel EZH1/2 inhibitor-based treatment strategies for follicular lymphoma, moderated by Dr Neil Love. Produced by Research To Practice. CME information and select publications here.

Top comments

Medical oncologist Dr Neil Love interviews clinical investigators on new research and practical application to general medical oncology practice.

www.researchtopractice.com

Switch to the Fountain App

Open in Fountain